Lee's Pharmaceutical's spinoff unit Zhaoke falls in Hong Kong debut

Lees Pharmaceutical Holdings

29/04/2021 03:41

** Shares of ophthalmic drugs maker Zhaoke Ophthalmology Ltd
 6622.HK  trade as low as HK$14.36 per share in Hong Kong debut,
14.5% below their offering price
    ** Stock last down 12.9% from the offering price of HK$16.80
apiece; among the 30 most actively traded by turnover
    ** The subsidiary of Hong Kong-listed Lee's Pharmaceutical
 0950.HK  sold 123.6 mln shares in Hong Kong IPO, raising
HK$2.08 bln ($268 mln) for clinical development,
commercialization of products and expanding manufacturing
facility  urn:newsml:reuters.com:*:nFWN2MK1GW
    ** Shares of Lee's Pharmaceutical fall 4.8% to the lowest
since March 9
    ** The Hong Kong Hang Seng Commerce & Industry Index  .HSNC 
gains 0.6%, and the benchmark index  .HSI  rises 1%




($1 = 7.7622 Hong Kong dollars)

 ((Reuters Messaging:
donny.kwok.thomsonreuters.com@reuters.net))